Alzheimer's Prevention Initiative Generation Program: Development of an APOE genetic counseling and disclosure process in the context of clinical trials

INTRODUCTION: As the number of Alzheimer's disease (AD) prevention studies grows, many individuals will need to learn their genetic and/or biomarker risk for the disease to determine trial eligibility. An alternative to traditional models of genetic counseling and disclosure is needed to provid...

Descripción completa

Detalles Bibliográficos
Autores principales: Langlois, Carolyn M., Bradbury, Angela, Wood, Elisabeth M., Roberts, J. Scott, Kim, Scott Y.H., Riviere, Marie-Emmanuelle, Liu, Fonda, Reiman, Eric M., Tariot, Pierre N., Karlawish, Jason, Langbaum, Jessica B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Featured Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944715/
https://www.ncbi.nlm.nih.gov/pubmed/31921963
http://dx.doi.org/10.1016/j.trci.2019.09.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944715/
https://www.ncbi.nlm.nih.gov/pubmed/31921963
http://dx.doi.org/10.1016/j.trci.2019.09.013

Ejemplares similares